Scynexis (SCYX) EBT Margin (2013 - 2026)
Scynexis' (SCYX) quarterly EBT Margin came in at 65.74% in Q4 2025, up 51712.0% YoY from N/an in Q4 2024, and up 102.56% on a QoQ basis from 2572.16% in Q3 2025.
Scynexis (SCYX) EBT Margin (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 12 years of EBT Margin data on file, last reported at 65.74% in Q4 2025.
- Quarterly EBT Margin rose 51712.0% year-over-year to 65.74% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 96.57% (up 94761.0% YoY) and the FY2025 annual result came in at 41.79%, up 52247.0% from the prior year.
- EBT Margin climbed to 65.74% in Q4 2025, from 2572.16% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 93.01% in Q2 2023 to a low of 4906.03% in Q4 2021.
- A 5-year average of 1139.41% and a median of 504.77% in 2025 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin surged 395984 bps — and 2025, when it plunged 216627 bps.
- Tracing SCYX's EBT Margin over 5 years: stood at 4906.03% in 2021, then surged by 81 bps to 946.19% in 2022, then jumped by 65 bps to 335.12% in 2023, then tumbled by 35 bps to 451.38% in 2024, then soared by 115 bps to 65.74% in 2025.
- The last three EBT Margin figures came in at 65.74% (Q4 2025), 2572.16% (Q3 2025), and 504.77% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | -3,017.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,017.02% |
| Dec 31, 2025 | 65.74% |
| Sep 30, 2025 | -2,572.16% |
| Jun 30, 2025 | -504.77% |
| Mar 31, 2025 | -2,097.67% |
| Dec 31, 2024 | -451.38% |
| Sep 30, 2024 | -485.30% |
| Jun 30, 2024 | -1,964.40% |
| Mar 31, 2024 | 68.61% |
| Dec 31, 2023 | -335.12% |
| Sep 30, 2023 | -99.77% |
| Jun 30, 2023 | 93.01% |
| Mar 31, 2023 | -2,997.88% |
| Dec 31, 2022 | -946.19% |
| Sep 30, 2022 | -1,900.06% |
| Jun 30, 2022 | -1,008.69% |
| Mar 31, 2022 | -1,450.14% |
| Dec 31, 2021 | -4,906.03% |
| Sep 30, 2021 | -126.94% |
| Mar 31, 2021 | -29.68% |